Tubidy
    ESGCT e-School: Learn from viruses to improve viral and non-viral vectors

    ESGCT e-School: Learn from viruses to improve viral and non-viral vectors

    01:14:50 |
    Download MP3

    Related Videos

    ESGCT e-School: Learn from viruses to improve viral and non-viral vectors 1:14:51

    ESGCT e-School: Learn from viruses to improve viral and non-viral vectors

    European Society of Gene & Cell Therapy 2015 5:23

    European Society of Gene & Cell Therapy 2015

    ESGCT e-School: Gene Therapy – From Concept to Proof 1:01:27

    ESGCT e-School: Gene Therapy – From Concept to Proof

    ESGCT e-Seminar: Combining Oncolytic Viruses and CAR-T Therapies 43:25

    ESGCT e-Seminar: Combining Oncolytic Viruses and CAR-T Therapies

    ESGCT e-School: Adenoviral vectors – gene delivery tool, powerful weapon in cancer and beyond 47:26

    ESGCT e-School: Adenoviral vectors – gene delivery tool, powerful weapon in cancer and beyond

    Oncolytic virotherapy 55:50

    Oncolytic virotherapy

    Qiagen 1:21

    Qiagen

    ESGCT e-School: How to teach enveloped vectors about cell entry targeting 47:21

    ESGCT e-School: How to teach enveloped vectors about cell entry targeting

    ESGCT e-School: Gene and cell therapies for Epidermolysis Bullosa 1:10:25

    ESGCT e-School: Gene and cell therapies for Epidermolysis Bullosa

    ESGCT e-Seminar: Virus-free gene editing of T cells 56:11

    ESGCT e-Seminar: Virus-free gene editing of T cells

    ESGCT e-School: Directing the immune response to specific tumor antigens using modified oncolytic vi 1:09:16

    ESGCT e-School: Directing the immune response to specific tumor antigens using modified oncolytic vi

    ESGCT e-Seminar: AROUND THE WORLD SERIES - the Coalition of International Gene Therapy Societies 58:51

    ESGCT e-Seminar: AROUND THE WORLD SERIES - the Coalition of International Gene Therapy Societies

    Sarepta ESGCT 2024 1:03

    Sarepta ESGCT 2024

    Stemmatters 1:06

    Stemmatters

    ESGCT e-Seminars: Intellia’s Modular CRISPR/Cas9 Gene Editing Platform for the Treatment of Disease 1:05:35

    ESGCT e-Seminars: Intellia’s Modular CRISPR/Cas9 Gene Editing Platform for the Treatment of Disease

    Gene Editing - from experimental to clinical trials 48:55

    Gene Editing - from experimental to clinical trials

    Labcorp cell and gene therapy 2:37

    Labcorp cell and gene therapy

    ESGCT e-Seminars: Safety considerations in therapeutic genome editing 59:35

    ESGCT e-Seminars: Safety considerations in therapeutic genome editing

    ESGCT e-School: The CNS - gene therapy for Alzheimer's disease and beyond 54:44

    ESGCT e-School: The CNS - gene therapy for Alzheimer's disease and beyond

    ESGCT e-School: The liver - main target in gene therapy 1:10:48

    ESGCT e-School: The liver - main target in gene therapy